Jeantet advises Medical Devices Venture on its listing on the euronext access + Paris market
Paris, on February 11, 2022, Jeantet advised Medical Devices Venture, a MedTech investment and acceleration platform, on its listing on the Euronext Access + Paris market, by way of direct admission following a €2.3 million private placement with industrial and financial investors in France and internationally.
Medical Devices Venture, a subsidiary of Archos (itself listed on the Euronext Growth Paris market), aims at building a leading French industrial group through a portfolio of MedTech companies offering innovative technologies based on medical devices or technologies serving healthcare, which can be industrialized on a large scale and in market segments offering the potential to hold leading niche positions.
The market capitalization of Medical Devices Ventures is approximately €14.3 million based on the €2.3 million private placement completed in the context of the listing.
The shares of Medical Devices Venture have been listed on the Euronext Access + Paris market since February 10, 2022 (ISIN: FR0014006PT9 / Mnemonic: MLMDV).
The purpose of the listing is to enable Medical Devices Venture to obtain better liquidity for its shares for all its shareholders, to gain visibility and to raise new funds to continue its development and that of its shareholdings.
In addition, Medical Devices Venture is considering, subject to market conditions and Euronext approval, a transfer on Euronext Growth Paris during 2022.
Allegra Finance acted as listing sponsor and Champeil as investment services provider.
Jeantet (legal counsel of Medical Devices Venture): Cyril Deniaud (Partner, Capital Markets) and Guillaume Soulé (Associate, Capital Markets).
Jeantet advises Mercury Engineering on a syndicated financing
Paris, July 2026 – Jeantet acted as French legal counsel to the MERCURY ENGINEERING group in connection with EUR 109,462,500 facilities, together with an accordion facility of up to EUR 100,000,000, acceded to by Mercury Engineering France. This financing was granted by a syndicate comprising in particular Allied Irish Banks, p.l.c., Citibank and Barclays, as […]
Paris | BANK-FINANCE-REGULATORY
JEANTET ADVISES CRODA INTERNATIONAL PLC ON A MULTICURRENCY NOTE ISSUANCE
Paris, June 2026 – Jeantet acted as French legal counsel to CRODA International PLC and its subsidiary SEDERMA SAS in connection with a multicurrency notes offering to US pension funds in an aggregate amount of £50,000,000 and €100,000,000. CRODA International PLC is one of the world’s leading manufacturers of specialty chemicals for cosmetics and personal […]
Paris | BANKING AND FINANCE LAW
JEANTET ADVISED IRIS VENTURES IN ITS STRATEGIC INVESTMENT IN KRÈME
Paris, July 31, 2026 – Jeantet advised Iris Ventures in its strategic investment in Krème, France’s leading dermocosmetics brand pioneering microbiome-powered skincare, fueling its next phase of growth. Founded in 2020 by Juliette Lailler and Marie Belile, Krème pioneers microbiome-based skincare for sensitive skin, combining probiotic ferments with pharmaceutical rigor in natural, high-tolerance formulas made […]
Paris
Jeantet advised Nexum Pharma on the acquisition of the assets of Livmed’s
Paris, July 22, 2026 – Jeantet advised Nexum Pharma on the acquisition of the assets of Livmed’s as part of the judicial liquidation proceedings before the Nice Commercial Court. Nexum Pharma is a French healthtech company specializing in the home delivery of pharmacy and parapharmacy products. Through this acquisition, Nexum Pharma strengthens its technological capabilities […]
Paris | Corporate / M&A / Private Equity
Jeantet advised Tevalia Capital in the conclusion of a strategic partnership with Alba Infra Partners
Paris, 20 July 2026 – Jeantet advised Tevalia Capital in the framework of the launch with Alba Infra Partners of Altevera, a pan-European renewable developer and energy generation platform. Alba Infra Partners, through its EOPF II fund, and Tevalia Capital have launched Altevera, a pan-European platform for the development and generation of renewable energy, focusing […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises the CPM group on acquisition financing granted by funds managed by Muzinich Co
Paris, July, 2026 – Jeantet acted as French legal counsel to CORPPERFORMANCE BIDCO AG, a Swiss company, as borrower, in connection with a Swiss law governed acquisition financing in an aggregate amount of EUR 45,000,000 to which CPM Partners SAS has acceded. The financing consists of a non-amortising acquisition/capex facility and a bridge credit facility, […]
| BANKING AND FINANCE LAW
Jeantet advises RGREEN INVEST on a €52.4 million investment in the holding company of the founder of Arverne Group
Paris, July 10, 2026 – Jeantet advised RGREEN INVEST on a €52.4 million investment in the holding company of the founder of Arverne Group, a company listed on the regulated market of Euronext Paris. RGREEN INVEST and Pierre Brossollet, founder and CEO of Arverne, a leading French provider of geothermal solutions listed on the regulated […]
| CAPITAL MARKETS AND STOCK EXCHANGE LAW | TAX
Jeantet advises Apollo Minerals Limited in the context of its listing on Euronext Growth Paris
Paris, 6 July, 2026 – Jeantet advised Apollo Minerals Limited, an Australian company specialized in the mineral exploration and development sector operating in France, Gabon and Serbia, on its listing on Euronext Growth Paris by way of direct admission, resulting in a market capitalization of circa €42 million. Apollo Minerals Limited is based in Perth, […]
Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW | LISTED COMPANIES AND CAPITAL MARKETS LAW
Jeantet advises Hoffmann Green Cement Technologies on its share capital increase by way of private placement intended for qualified investors
Paris, June 29, 2026 – Jeantet has advised Hoffmann Green Cement Technologies, a company listed on Euronext Growth Paris, on its share capital increase by way of private placement intended for qualified investors. The share capital increase involved the issuance of a total of 1,271,485 shares, representing a total share capital increase of circa €5 […]
| CAPITAL MARKETS AND STOCK EXCHANGE LAW
Jeantet advises Media 6 and its controlling shareholder Vasco in connection with the public buy-out offer followed by a squeeze-out on Media 6 shares launched by Vasco
Paris, June 30, 2026 – Jeantet advised MEDIA 6, a company specialized in the design and merchandising of physical retail locations for major luxury brands across the Asia-Pacific, Europe, and North America regions, in connection with the public buy-out offer on its shares, launched by its controlling shareholder Vasco (acting in concert with the Vasseur […]
Paris | LISTED COMPANIES AND CAPITAL MARKETS LAW
JEANTET HAS ADVISED EMMI AI’S SHAREHOLDERS IN CONNECTION WITH ITS ACQUISITION BY MISTRAL AI
Paris, May 19, 2026 – Jeantet advised the shareholders of Emmi AI alongside the Austrian law firms Dorda and Schönherr, in connection with the acquisition by Mistral AI of the entire share capital of Emmi AI. This merger aims to combine Mistral AI’s leading AI systems with Emmi AI’s unique expertise in AI applied to […]
| CORPORATE – M&A – PRIVATE EQUITY | TAX LAW
Jeantet announces the promotion of six new Counsels
Paris, May 12, 2026 – Jeantet is pleased to announce the promotion of six new Counsels: Perrine Fuchs (Corporate M&A), Juliette Hubert (Employment Law), Maria Plakci (M&A, Private Equity), Georges-Dominic Sardi (M&A, Venture Capital), Jessica Sellem (Tax Law) and Hugues Vaysset (Banking and Finance Law). “These promotions reflect the excellence, commitment, and professionalism of Perrine, […]